logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

拜登宣布向全球釋出75%未用新冠疫苗 包括台灣

總統拜登週四宣布,美國將向全球捐出75%未用的新冠疫苗,分配機制將透過COVAX 全球疫苗分享計畫來執行,其中有700萬劑送往亞洲,包括台灣。

白宮今天接露第一批會先向全球分享2500萬劑疫苗。美國總計在六月底前,將會分享8千萬劑的疫苗給其他需要疫苗的國家。拜登政府表示,其中有25%的疫苗會保留,直接給予美國的盟友與合作夥伴緊急使用,75%透過COVAX分享。

拜登表示,只要這場大流行在世界任何地方還在持續,美國民眾就仍處在危險當中。美國致力於對全球展示對國際緊迫性的同等關心。

國務卿布林肯(Antony Blinken)稍早已透漏,拜登本週就會宣布向全球分配8000萬劑新冠狀病毒疾病(COVID-19)疫苗的計畫。

布林肯在哥斯大黎加首都聖約瑟(San Jose)的美國大使館表示:「這幾天…可能最快明天,總統會就他安排推出8000萬劑疫苗到全世界的計畫,宣布更多細節。」

布林肯重申,美國分配疫苗的計畫將與Covid-19疫苗全球取得機制(COVAX)協調,以需求為基礎,「沒有任何附加政治條件」。

過去幾個月,拜登政府幕僚和聯邦衛生官員一直在討論如何分享額外的疫苗劑量,美國承受協助其他國家的沉重壓力,拜登自己和高階幕僚都收到盟友尋求協助的要求。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 大型建築工地頻發致命事故 紐約市房屋局展開清查
Next post 紐約市警與聯邦煙酒武器局攜手打擊槍支暴力

即時新聞

成本削減撐獲利 輝瑞Q3業績優預期上修全年展望

November 4, 2025

哈佛大學醫學院爆炸案 麻州兩名男子被捕

November 4, 2025

聯邦運輸部長: 若政府持續停擺或關閉部份空域

November 4, 2025

前副總統切尼因病逝世 享年84歲

November 3, 2025

OpenAI與亞馬遜簽380億元協議 擴大雲端運算

November 3, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy